The same group [57] later examined carvedilol, an alpha- and beta-adrenergic blocker, to treat canine pacing-induced heart failure, and observed that the interdomain interaction within RyR was defective in the failing heart, but the domain interaction remained normal in carvedilol-treated dogs, with preserved cardiac function. This evidence concerns the gene RYR2 and heart failure.